Skip to main content

Table 1 Anthropometirc measures of obese patients with NT, pre-HT and HT and their plasma metabolic parameters (vs their control group)

From: Association of cardiac NT pro-β-type natriuretic peptide with metabolic and endothelial risk factors in young obese hypertensive patients: a perspective on the hypothalamic pituitary adrenal axis activation

 

Control-patients (N = 30)

Obese patients

NT (N = 20)

Pre-HT (N = 20)

HT (N = 20)

Age (years)

14.5 ± 1.5

13.8 ± 0.9

14.7 ± 1.6

15.1 ± 1.1

Gender (M/F)

18/12

9/11

9/11

9/11

Diastolic BP (mmHg)

72. 5 ± 5.2

80.3 ± 2.1*

83.1 ± 2.5*

87.3 ± 2.6*, # a

Systolic BP (mmHg)

114 ± 6.1

117.5 ± 3.4

128.1 ± 3.9*, #

147 ± 6.5*, #, a

BMI

21.2 ± 1.2

32.9 ± 0.5*

32.2 ± 0.7*

33.6 ± 0.6*

Glucose (mg/dl)

78.2 ± 4.7

105.4 ± 3.3*

113.6 ± 1.8*, #

125.6 ± 5.3*,#, a

Insulin (µIU/ml)

5.5 ± 0.7

8.5 ± 0.4*

10.5 ± 1.5*, #

13.5 ± 0.7*, #, a

HOMA-index

1.1 ± 0.1

2.2 ± 0.03*

2.9 ± 0.06*

4.1 ± 0.09*, #, a

TG (mg/dl)

75.8 ± 10.4

198.7 ± 19.7*

206.5 ± 28.9*

215.9 ± 22.5*

TC (mg/dl)

132.1 ± 7.2

289.2 ± 16.7*

299.2 ± 30.7*

312.5 ± 21*, #

LDL-C (mg/dl)

77.2 ± 4.7

199.6 ± 12.8*

208. 5 ± 23.9*

218.9 ± 13.7*, #

HDL-C (mg/dl)

39.73 ± 3.5

49.75 ± 3.8*

49.46 ± 4.1*

50.53 ± 3.8*

Metabolic syndrome

No

No

Yes

Yes

  1. Values are mean ± SD for control healthy, obese normotensive, prehypertensive and hypertensive patients groups
  2. Values (*) is significantly different from control group; (#) significantly different from normotensive obese patients, (a) significantly different from prehypertensive obese patients
  3. Values are statistically significant at P < 0.05 using one way ANOVA with LSD as post hoc test. (SPSS program)